Table 4:
Summary of the results of other outcome measures
| Outcome indicator | No. of trial | P; I2 | Model for meta-analysis | Effect size | 95%CI | P |
|---|---|---|---|---|---|---|
| Recurrence rate | 12 | P=0.008; I2=56% | RE | OR=0.17 | 0.10–0.31 | <0.001 |
| Gastric emptying rate | 7 | P=0.03; I2=57% | RE | MD=11.97 | 9.90–14.03 | <0.001 |
| Motilin | 2 | P<0.001; I2=96% | RE | MD=−93.94 | −142.34- −45.53 | <0.001 |
| Adverse effects rate | 3 | P=0.49; I2=0% | FE | OR=1.74 | 0.36–8.48 | =0.49 |
RE, random-effects model; FE, fixed -effects model; OR, odds ratio; MD, mean difference.